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Inhibition by indomethacin of adaptive changes
in the contralateral kidney after release of
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Over the past several years, the pathophysiologic alterations
in obstructive nephropathy have received considerable atten-
tion [I]. in most instances, the changes that occur during the
period of ureteral occlusion or immediately after release of
obstruction have been studied. The alterations in renal hemody-
namics and function differ considerably in animals subjected to
acute unilateral ureteral occlusion (UUO) and those subjected
to bilateral ureteral occlusion (BUO) [l—3J. In animals subjected
to UUO, the contralateral unoperated kidney is frequently used
as a control organ [Ii.
Although the compensatory changes that occur after the loss
of renal function or mass are well known, the adaptive alter-
ations in renal function and hemodynamics that occur in the
contralateral kidney after release of ULJO have not been well
delineated, and the mechanisms responsible for those changes
are unknown. During the investigations of the pattern of
recovery from an obstructive renal injury, we noted previously
undescribed adaptive changes in the contralateral kidney that
occurred 24 hours after release of UUO. The present study was
designed (1) to delineate the adaptive changes in the contralat-
eral kidney after release of UUO, (2) to compare those adaptive
changes to the compensatory changes that occur following the
loss of renal mass or function, and (3) to determine if the
adaptive changes could be altered by the infusion of indometh-
acm.
Methods
Experiments were performed on male Sprague-Dawley rats
(Charles River Breeding Laboratories), each weighing 200 to
300 g. Four groups of rats were studied (Table 1). Group A
served as sham-operated control animals. These rats were
sham-operated under pentobarbital (30 mg/kg; i.p.) anesthesia
on day I and day 2. In group B animals, a right unilateral
nephrectomy was performed on day I using pentobarbital
anesthesia. No surgical procedure was carried out on day 2. In
group C, the right ureter was completely occluded with a silk
ligature through a small suprapubic incision on day I and that
ureter remained occluded throughout. In group D, the right
ureter was obstructed by tying three 5-mm silastic strips around
the lower ureter with a silk ligature on day I. At the beginning of
day 2, the ureteral occlusion was released. Following surgical
preparation, all animals were returned to their cages and
allowed free access to food and water. Animals were weighed
before surgery and then daily.
Approximately one half of the animals in each group received
an i.v, infusion, over 3 to 5 mm of indomethacin (10 mg/kg;
conc. 10 mg/mI) at the beginning of day I and day 2, whereas the
other half of the rats were infused with an equivalent volume of
isotonic saline. In all groups of animals, glomerular filtration
rate and total renal blood flow were determined in the left,
unoperated, contralateral kidney at the end of day 2 (beginning
of day 3).
The rats were anesthetized with lnactin (100 mg/kg, i.p.;
Promonta, Hamburg) and placed on a heating board with a
temperature probe monitor and tracheotomized. Polyethylene
catheters (PE5O) were secured into the external jugular vein,
left carotid artery, left femoral artery, and urinary bladder. The
right ureter was also catheterized in group D animals to study
each kidney independently.
After replacement of surgical losses with isotonic saline eciual
to 2% of body wt, a priming dose of 10 p.Ci of 3H-methoxy
inulin (New England Nuclear Corp.) was given, followed by a
sustaining infusion of 10 i.Ci/hr in a volume of 1.2 ml. After a
45-mm equilibration period, inulin clearance (C1) was deter-
mined by the average of three 10-mm urine collections. Blood
samples were obtained from the tail at the midpoint of each
urine collection. The concentration of 3H-methoxy inulin was
determined with a Tri-carb liquid scintillation counter. After
completion of the clearance periods, total renal blood flow
(TRBF) was measured by an isotope-labeled microsphere tech-
nique, as described previously [4]. In all experiments, micro-
spheres (15 2 3M Corp.) labeled with strontium 85 were
diluted with 20% dextran to a final concentration of 60,000 per
0.1 ml and 2 drops of Tween-80 were added. Immediately
before injection, each sample was mixed for 3 mm by an
ultrasonic dismembranator (Artek System ARP). Then, 0. I nil
of the 85Sr-Iabeled microspheres was injected via the left carotid
artery into the root of the aorta, and simultaneously blood was
withdrawn from the femoral artery at a rate of 1.03 mI/mm. The
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a Infusion was given on both day I and day 2 in each group. All studies were performed at the end of day 2 in each group.
Total RBF
Indoniethacin
2802 207
3381 185
3680 221
2892 248
rats were sacrificed; each kidney was removed and weighed
after stripping the capsule. The activity (counts/mm) of isotope
was determined in a gamma counter (Packard). C1, and TRBF
were calculated from standard formulae [4, 5].
All values are given as the means SEM. Analysis of variance
and Student's t test were used to determine the significance of
differences between groups, where appropriate.
Results
At the time of study, the final body weight was similar in all
four groups of rats. The indomethacin-treated and saline-
infused animals within each group also had similar final body
weight and mean arterial blood pressure (108 6 mm Hg).
Despite free access to food and water, all animals lost weight
following surgical preparation.
The functional changes in the unoperated, contralateral, left
kidney are shown in Table 2. In the saline-treated animals, the
following results were found. (I) Urinary flow rate was in-
creased in the group B, C, and D rats (2.79 0.22, 2.68 0.10,
and 3.81 0.34 p.l/min/lOO g of body wt, respectively; control
value, 1.55 0.10). (2) As expected, a small but significant
increase in GFR occurred in animals with unilateral nephrecto-
my, group B (756 21 p.l/min/lOO g of body wt), and continued
unilateral ureteral occlusion, group C (758 41), whereas group
D animals, in which the ureteral obstruction had been released
for 24 hours, had adaptive increases in GFR (1020 43) that
were unexpectedly greater than that in either group B or group
C animals (P < 0,01). In fact, the level of GFR achieved in the
contralateral kidney of group D rats was about twice the control
values and approximately the value seen in normal rats with
two intact kidneys. (3) The compensatory changes in TRBF
were similar to the changes in C1,, with a moderate increase in
TRBF in groups B and C animals. But, in group D animals, the
— Saline
lndomethacin
TRBF (4552 292 .d/min/l 00 g of body wt) exceeded the values
in groups B and C and reached a value almost twice the control
levels (P < 0,01),
Approximately one half of the animals in each group received
indomethacin (10 mg/kg) i.v. on day 1 and day 2. The functional
studies of the contralateral, unoperated kidney, which were
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Table 1. Adaptive changes of the contralateral kidney in unilateral ureteral occlusion'
Animal preparation No. of animals infused
Day I Day 2 Saline Indomethacin
Group A Sham operated Sham operated 12 10
Group B Rt unilateral nephrectomy None 14 Il
Group C Unilateral ureteral occlusion Continued occlusion II 10
Group 0 Unilateral ureteral occlusion Occlusion released
Total
12
49
14
45
Table 2. Functional changes in the contralateral kidney'
Urinary flow rate GFR
Saline Indomethacin
Group A (sham operated) 1.55 0.10
Group B (right nephrectomy) 2.79 + 0.22"
Group C (continued occlusion) 2.68 0.10"
Group D (occlusion released) 3.81 0.34""
a All values are given as IAI/min/100 g of body wt for a single kidney. All values are mean SEM.b P < 0.01, saline-treated animals vs. group A.
P < 0.01, saline vs. indomethacin within same group.
d p < 0.01, indomethacin-treated animals vs. group A.
P < 0.01 group D vs. group C.
<0.05 group D vs. group C.
1.32 0.13
2.37 03.,d
2.11 021d
2.34 0.19"
Saline Indomethacin
595± 18 578÷18
756 21" 697 26"
758 41" 670 26d
1020 43"" 592 48"
Saline
2745 275
3330 277
3636 315
4552
P < 0.01
P - NS P = NS
Group A, Group B, Group C, Group D,
sham unilat. continued occlusion
Nx occlusion released
Fig. I. Glomerular filtration rate measured by inulin clearance (C,,,) in
the contralateral kidney of animals treated with nor/na! saline and
indomethacin. Groups B and C demonstrate a mild compensatory
increase in inulin clearance after the removal of one kidney or the
complete continued occlusion of one ureter. The adaptive increase in
inulin clearance in the saline-treated group D animals is in excess of the
changes in groups B or C. Treatment with indomethacin had no effect
on the animals in groups A, B, or C, but markedly reduced inulin
clearance in group D animals.
Unilateral zireteral occlusion 693
Table 3. Functional changes in the ipsilateral kidney'
Group A (sham operated) 595 18 578 18
Group D (occlusion released) 295 127 28C
All values are given as i.l/min/l00 g body wt for a single kidney. All values are the mean SEM.
b P < 0.01, saline-treated animals vs. group A.
P < 0.01, saline vs. indomethacin within same group.
carried out 24 hours after the second dose of indomethacin, are
shown in Table 2 and Figure 1. The infusion of indomethaciri
significantly reduced urinary flow rate only in group D animals
(3.81 0.34 for saline vs. 2.34 0.19 for indomethacin, P <:
0.01). Similarly, the prior infusion of indomethacin did not alter
the compensatory changes in GFR or TRBF in either group B or
C rats, whereas this agent essentially eliminated the adaptive
changes in both GFR (1020 43 for saline vs. 592 48 for
indomethacin, P < 0.01) and TRBF (4552 292 for saline vs.
2892 248 for indomethacin, P < 0.01) in group D animals, In
fact, the GFR and TRBF were reduced to control values in
these animals in which the ureteral occlusion had been released
concomitant with the second dose of indomethacin.
Functional changes in the ipsilateral kidney could only be
determined in animals from group A and group D (Table 3). In
group D animals treated with saline. GFR was reduced below
control values (295 38, P < 0.01), and TRBF was similar to
group A (P = NS). Because the values for GFR and TRBF are
greater than those previously reported 1 hour after release of
unilateral ureteral occlusion [3], it would suggest that the
techniques used allowed a successful release of the previously
occluded ureter. In the group D animals treated with indonieth
acm, the recovery of both GFR (127 28, P <0.01) and TRBF
(1688 135, P < 0.01) in the ipsilateral kidney was completely
abolished.
Discussion
The pathophysiologic response to ureteral occlusion has been
extensively investigated [1—3, 6—Il]. Most studies have focused
attention on changes that occur during the period of obstruction
or during the first I to 3 hours after release of obstruction and
in studies of UUO, the contralateral kidney is assumed to have
normal function. Consequently, the impressive functional and
hemodynamic alterations in the contralateral kidney, which
were observed in this study 24 hours after release of UUO,
were initially quite unexpected. In the saline-treated animals of
the present study, it becomes clear that the adaptive increases
in GFR and TRBF exceed the compensatory changes that are
usually seen following loss of renal mass or renal function [5,
121.
Approximately one half of the animals in each group was
treated with indomethacin in an attempt to modify this adaptive
renal response. This agent did not have any effect on sham
operated control animals. Indomethacin also failed to diminisl'
the compensatory response to loss of renal mass or function
(Fig. I, groups B and C). On the other hand, this agent
completely obliterated the adaptive response following release
of ureteral occlusion (group D). It is tempting, therefore, to
suggest that this adaptive response is prostaglandin mediated.
Needleman and Morrison [13, 14] have shown that ureteral
occlusion is a potent stimulus to prostaglandin synthesis, and
Smith and Bell [15] have demonstrated prostaglandin forming
cyclo-oxygenase in the endothelial cells of arteries and arter-
ioles of the renal cortex. In addition, Allen, Vaughan, and
Gillenwater [161 were able to alter the renal hemodynamic
response during UUO by the continuous infusion of indometh-
acm in the dog. Thus, there is ample precedent for the involve-
ment of prostaglandins in obstructive renal injury.
The mechanisms whereby the release of ureteral occlusion in
one kidney may stimulate functional and hemodynamic changes
in the contralateral kidney are of considerable interest. It is
generally thought that the vasodilatory properties of the prosta-
glandins are removed by a single passage through the pulmo-
nary circulation. Thus, a direct effect of prostaglandins released
from the previously obstructed ipsilateral kidney would seem
unlikely. But, Papariicolaou and Meyer [17] have shown that
only 32 to 35% of the vasodilatory properties of the prostaglan-
dins are removed in one passage of the lungs of an unanesthe-
tized rat. Consequently, a direct effect of prostaglandins re-
mains a possibility. Another possibility would be an indirect
stimulation of prostaglandin biosynthesis via the renin-angio-
tensin system. Vander and Miller [181 and Vaughan, Sherasky,
and Gillenwater [111 have shown that manipulation of the ureter
may stimualte the urinary and venous excretion of renin.
Several investigations have demonstrated that angiotensin II
will stimulate renal prostaglandin synthesis [19]. It is possible,
therefore, that the release of a previously occluded ureter will
stimulate renin secretion, which could promote the synthesis of
prostaglandins in the contralateral kidney.
Interpretation of the effect of indomethacin as being specific
for prostaglandin inhibition after release of UUO requires
careful consideration for several reasons: (I) urinary, venous,
and tissue levels of prostaglandins were not determined, (2)
although prostaglandin infusions may result in marked vasodili-
tation in some species [19, 20], the hemodynamic effects in the
rat are not well established [19, 201, (3) increases in GFR similar
to those observed in our group D animals have not been
previously attributed to prostaglandins [19, 201, and (4) it must
be recognized that indomethacin may inhibit other enzyme
systems. Nonetheless, the impressive changes in GFR and RBF
seen when the animals were studied 24 hours after release of
UUO have not been appreciated previously when similar obser-
vations were made immediately after release of UVO [1, 3]. The
present data also suggest that the contralateral kidney in UUO
cannot be assumed to have normal function, and that this
kidney should not be used as the control organ in studies of
obstructive nephropathy.
GFR
Saline Indomethacin
RBF
Saline
2745 275
2505 150
Indomethacin
2802 207
1688 l35C
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The data from this report also provide some new insight into
the process of recovery from UUO. In the saline-treated
animals 24 hours after release of UUO, the GFR and TRBF in
the ipsilateral kidney were approximately twice the values
previously reported from our laboratory I hour after release of
UUO [3]. Following the administration of indomethacin, these
values returned to levels similar to those reported I hour after
release of UUO. Jaenike 171 proposed that preglomerular vaso-
constriction was responsible for the impaired function immedi-
ately following release of UUO. The data from the present
study would suggest that during the first 24 hours after release
of UUO, progressive renal vasodilatation plays an important
role in initiating recovery in the ipsilateral kidney, and that the
recovery of GFR and TRBF can be inhibited by the infusion of
indomethacin.
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